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Abstract
Small non coding RNAs are a group of very different RNA molecules, present in virtually all cells,
with a wide spectrum of regulatory functions which include RNA modification and regulation of
protein synthesis. They have been isolated and characterized in all organisms and tissues, from
Archaeobacteria to mammals. In mammalian brain there are a number of these small molecules,
which are involved in neuronal differentiation as well as, possibly, in learning and memory. In this
manuscript, we analyze the present knowledge about the function of the most important groups of
small non-coding RNA present in brain: small nucleolar RNAs, small cytoplasmic RNAs, and
microRNAs. The last ones, in particular, appear to be critical for dictating neuronal cell identity
during development and to play an important role in neurite growth, synaptic development and
neuronal plasticity.
Introduction
In recent years it has become more and more clear that
RNA cannot be any longer classified as ribosomal, mes-
senger and transfer RNA (rRNA, mRNA, tRNA); instead a
number of different RNA molecules have been character-
ized, which are involved in a variety of cellular regulatory
processes on their own or as a part of ribonucleoprotein
particles (RNPs) [1]. Small nuclear RNAs (snRNAs), small
nucleolar RNAs (snoRNAs), microRNA (miRNAs), just to
name a few, have revolutionized our view of cellular
molecular machineries. It is now predicted that as much
as 40–50% of mammalian mRNAs could be regulated at
the translational level by miRNAs and that 50–60% of
mammalian pre-mRNAs could be alternatively spliced, by
a process critically involving snRNAs, to form a huge
number of different proteins.
A number of small non-coding RNAs have been detected
in mammalian brain; among them, some appear to be
brain specific. They have been related to brain develop-
ment, neuronal differentiation and complex functions
such as learning and memory; some have also been impli-
cated in neuronal degeneration and mental disorders.
Small nucleolar RNA
All eukaryotic cells contain a large number of small ribo-
nucleoprotein particles (snoRNPs) active in rRNA
processing, modification and ribosome assembly. These
particles are formed by a single snoRNA molecule and a
set of proteins. SnoRNAs, and snoRNPs, can be of two dif-
ferent classes: "C/D box", containing conserved sequences
named boxes C and D, and "H/ACA box", again contain-
ing conserved sequences with those names (Figure 1). Dif-
ferent proteins bind to the two classes, forming the
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ribonucleic particles snoRNPs [2]. These snoRNPs, more
specifically their snoRNA component, target specific
sequences on pre-rRNA for nucleotide modification: box
C/D snoRNAs cause 2'-O methylation [3] while the box
H/ACA ones give rise to pseudouridylation [4]. In both
these processes, the modification reactions are guided by
the joining of complementary regions, extended for 10–
21 nt, between the rRNA and the snoRNA. The same reac-
tion of site specific nucleotide modification occurs on
rRNA, tRNA, snRNA and, most probably, mRNA. rRNA
and tRNA nucleotide modifications are thought to
improve translation efficiency while modification of
other RNA molecules probably affects their folding.
Most mammalian snoRNAs are ubiquitous, but some are
expressed exclusively in brain. This suggests that these
molecules are not needed for normal housekeeping, but
are important for brain function. Six C/D box and one H/
ACA box RNAs have been isolated from mouse brain.
MBII-13 and MBII-78 are encoded by single copy genes
while MBI-36 (H/ACA), MBII-48, MBII-49, MBII52 and
MBII85 are encoded by multiple copies [5]. Human
homologues of these snoRNAs are also highly expressed
in brain while a couple of them, HBII-13 and HBII-85, are
also found in other tissues [6]. In situ hybridizations
revealed that MBI-36, MBII-48, MBII52 and MBII85 are
not expressed uniformly in brain. They are concentrated
in hippocampus and amygdala, two areas very important
for brain functions such as spatial learning and fear con-
ditioning. Furthermore, inside the hippocampus, a differ-
ence exists between dorsal and ventral regions: MBI-36,
MBII-48, MBII52 have a higher expression in ventral with
respect to dorsal hippocampus, suggesting that these
snoRNAs play a differential role [7].
The function and molecular mechanisms of brain specific
snoRNAs remain unknown. They have no complementa-
rity to rRNA, so they are probably not involved in rRNA
processing or modification. Their peculiar hippocampal
expression pattern, however, raises the intriguing possibil-
Schematic secondary structure of the two classes of snoRNAs Figure 1
Schematic secondary structure of the two classes of snoRNAs. A) H/ACA box snoRNAs fold into "hairpin-hinge-hair-
pin-tail" structures and contain two short sequences called boxes H and ACA, as indicated in the white boxes. The hairpins are 
interrupted by an internal loop that forms the pseudouridylation pocket. A set of conserved proteins, Nhp2, Gar1, Cbf5 and 
Nop10, recognize and bind to this structure. B) C/D box snoRNAs show conserved boxes termed C (UGAUGA) and D 
(CUGA), positioned near their 5' and 3' termini. Sometimes two additional, less conserved, boxes called C' and D' are present. 
C and D boxes form a characteristic secondary structure: the K-turn motif. Four evolutionary conserved proteins are associ-
ated to it: Snu13 (15.5K in human), that recognizes the internal loop [111], Nop58 and Nop1 (Fibrillarin in human) that cross-
link to the U in box C and the U in box D, respectively [112]. In yeast, Nop58 and Snu13 are necessary for the accumulation of 
all C/D box snoRNAs [113], Nop1 is essential for the production of a subset of box C/D snoRNAs, and Nop56p is not essen-
tial for snoRNA accumulation [114].
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ity that they are involved in memory consolidation. In
fact, ventral hippocampus has been demonstrated to be
very important in contextual conditioning, a form of asso-
ciation of stimuli with the context [8]. While MBI-36
expression does not change in contextual memory consol-
idation, MBII-48 and MBII52 expression is transiently reg-
ulated, being lower for the first and higher for the second.
Furthermore, this variation is strictly associated with con-
textual conditioning and it is not induced by a different
kind of stimulation [7]. As stated above, the molecular
mechanism of action of these RNAs remains obscure.
However, they have a complementarity to mRNAs for pro-
teins involved in memory processes like for instance 5-
HT2C mRNA, coding for the serotonin 2C receptor. This
receptor is involved in memory consolidation [9,10]; edit-
ing and alternative splicing of its mRNA have been associ-
ated with mental disorders such as schizophrenia [11,12].
Human homologues of MBII-13, MBII-52 and MBII-85
map on chromosome 15q11-13 region, which is associ-
ated with Prader-Willi syndrome (PWS), a neuro-behav-
ioural disorder leading to mental retardation [13,14].
Later studies restricted the PWS locus to a small region
containing only the HBII-85 gene, indicating a strong
association of this snoRNA with the disorder [15].
Small cytoplasmic RNA
Brain cytoplasmic RNAs were discovered 20 years ago and
are one of the first examples of active genes derived from
retro-transposition [16,17]. BC1, in rodents, and BC200,
in primates, have similar expression patterns and proba-
bly play similar roles in neuronal cells.
BC1 is encoded by the mouse bc1 gene located on chro-
mosome 7; it is transcribed by RNA polymerase III and
derives from a retro-transposition event of tRNAala. This
tRNA gene is believed to be at the origin of Short Inter-
persed Repetitive Elements (SINEs) rodent sequences,
which are similar to Alu sequences in primates. Mutations
in re-transposed copies of the gene during evolution
would have changed the structure of the RNA molecule
from a typical tRNA to a complex stem-loop, changing at
the same time the functionality of the molecule [18]. The
human gene coding for BC200, bcyrn1, is also transcribed
by RNA polymerase III and is located on chromosome 2.
BC200 is structurally similar to BC1 and contains three
structural domains: the 5' domain, similar to the Alu
repetitive element, a central domain rich in adenines, and
the 43 nt long 3' terminal domain [19].
BC1 RNA is found only in neural tissues [20], and is
present in widely different amounts in different brain
structures: it is highly expressed in olfactory bulb, hippoc-
ampus and cortical neurons, while it is absent or present
in very low quantity in other brain areas [21]. The cellular
localization of BC1 is also peculiar: it is found in axons
and concentrated in somato-dendrites [22]. BC200 share
the same localization: it is expressed in neurons and trans-
ported to dendrites [19]. The intra-cellular localization of
BC1 and BC200 suggests their involvement in regulation
of translation in dendrites and synapses. In fact, these
RNAs bind to fragile × mental retardation protein
(FMRP), a protein that inhibits translation of specific
mRNAs at synapses [23,24]. BC1 and BC200 can probably
guide FMRP to specific targets, as they have regions of
complementarity to different mRNAs, also localized at
synapses, like Arc, MAP1B and αCaMKII. These mRNAs
code for proteins involved in synaptic plasticity phenom-
ena such as long term potentiation (LTP), implicated in
learning and memory [25,26]. Furthermore, BC1 and
BC200 have been shown to inhibit small ribosomal sub-
unit recruitment on some mRNAs [27] and to associate
with the polyA binding protein PABP [28]. BC1 RNA pro-
duction is regulated during neuronal development and
during changes in neuronal activity [29]. BC200 expres-
sion seems also to be related to Alzheimer's disease: brains
of Alzheimer's patients show a strong reduction of BC200
accumulation, linking these RNAs with neuro-degenera-
tive disorders [30]. Knock-out mice for the bc1 gene have
been generated. They develop normally, but show defects
in activity and an increased anxiety. On the other hand,
they do not show defects in learning and memory proc-
esses [31], indicating that, if BC1 is involved in these proc-
esses, some unknown activity must be present to replace
it.
MicroRNA
miRNAs are small RNA molecules involved in regulation
of gene expression by sequence specific pairing with
mRNA 3' UTRs (untranslated regions) and subsequent
inhibition of translation or mRNA degradation [32]. In
the recent past, the number as well as the overall impor-
tance of these small molecules have increased dramati-
cally: it is now postulated that expression of as much as
50% of mammalian mRNAs could be regulated in such a
way [33]. Gene expression control is finely directed by the
concerted action of transcription factors and miRNAs
(Figure 2). Work in model organisms has given support to
the idea that miRNAs have a pivotal function in cell differ-
entiation and the maintenance of cell identity in metazoa,
serving as agents for decisions among cells of related fates
[34]. Clear examples are found in C. elegans. The two miR-
NAs lsy-6 and miR-237 controls the left/right asymmetry
of chemo-sensory receptor expression in taste receptor
neurons, through repression of a homeobox transcription
factor [35]; miRNA-61, a direct transcriptional target of
LIN-12/Notch signaling, determines vulval precursor cells
to adopt a spatial pattern [36]. In zebrafish, miR-430 fam-
ily miRNAs are required for neurogenesis. In Drosophila,
the bantam miRNA regulates cell proliferation and death
by targeting the pro-apoptotic gene hid [37]. Only a fewBMC Neuroscience 2006, 7(Suppl 1):S5
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targets have been validated in mammalian systems, and
the role of miRNAs is less clear [38]. The current view is
that, likewise the situation in model organisms, mamma-
lian miRNAs are involved in restricting the fate of progen-
itor cells. This task is particularly important for the
nervous system, in which a vast variety of cell types is
derived from a single cell lineage. The role of miRNAs
continues beyond development, as these molecules oper-
ate in the adult brain as well, where they may function in
the local regulation of mRNA translation, playing an
important role in axon guidance, synaptic development
and neuronal plasticity.
MicroRNA biogenesis
Biogenesis of miRNAs is a multi-step process beginning
with transcription by RNA polymerase II of a primary
transcript, called pri-miRNA. This precursor associates
inside the nucleus with other factors, still largely
unknown, to form a large complex of 650 kDa that cleaves
out a 70 nt long stem-loop precursor RNA (pre-miRNA).
The cleaving enzymatic activity resides in an RNAse III
type endonuclease called Drosha [39]. The 650 kDa com-
plex also contains a double stranded RNA binding protein
encoded by a gene deleted in DiGeorge syndrome [40].
RanGTP exportin 5 transports pre-miRNA to the cyto-
plasm [41], where another RNAse III, Dicer, cleaves the
stem-loop structure to produce 20–22 nucleotide miRNA
duplexes [42]. One of the two RNA strands is then
included into the RNA-induced silencing complex (RISC)
[43]. Which strand is included into RISC is determined by
the different thermodynamic stability of the two ends of
the duplex. The strand with relatively unstable pairs at the
5' end is thought to remain as a mature miRNA. In case
the two ends are equally stable, both strands can be incor-
porated into RISC and function as a mature miRNA [44].
RISC is again a large complex, in which members of the
PIWI/PAZ domain containing proteins (Argonaute, AGO)
are the principal components. The fact that different
Combinatorial control of transcription and translation on gene expression Figure 2
Combinatorial control of transcription and translation on gene expression. Protein production depends on the 
resultant of transcription and translation events, in which transcriptional activators (TAs) and microRNAs (miRs), respectively, 
are major effectors. Other important post-transcriptional events are not indicated here, but are reviewed in [115]. Cell con-
text specific combinations of TAs and miRs determine protein A biosynthesis:1) The cell on the left (blue context) has a large 
amount of transcription activators for gene A promoter and a small amount of miR interacting with the 3' UTR of gene A 
mRNA. As a result of the strong transcription and the low inhibition of translation, protein A is abundant in this cell. 2) On the 
contrary, in the cell on the right (orange context) the few TAs and the high numbers of 3' UTR interacting miRs determine a 
low production of protein A.
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members of this protein family are contained in RISC is
responsible for the remarkable heterogeneity among such
complexes [45].
In humans, Ago2 (hAgo2) is associated with both siRNA
and miRNA, and mediates RNA cleavage targeted by small
RNAs; however, other Argonaute subfamily members,
such as hAgo1, hAgo3, and hAgo4, do not mediate such
RNA cleavage, although all can associate with siRNA and
miRNA [46,47].
RISC has multiple functions: it stabilizes the target strand,
guides the strand to target mRNAs and, depending on the
degree of complementarity between miRNA and target,
activates endonucleolytic cleavage of the mRNA, probably
when there is a perfect pairing, or translational inhibition,
when pairing is not perfect.
MicroRNA detection
miRNAs are easily detected through a number of tech-
niques, such as Northern blot analysis with miRNA spe-
cific probes, sequence-directed cloning and sequencing,
primer extension followed by real time PCR, and high
throughput oligonucleotide microarrays [48]. Locked
nucleotide RNAs (LNAs) are a new class of bicyclic high-
affinity RNA analogues containing a furanose ring in the
sugar-phosphate backbone which is chemically locked in
an N-type (C3'-endo) conformation by the introduction of
a 2'-O, 4'-C methylene bridge [49,50]. LNA-modified oli-
gonucleotides exhibit exceptionally high affinity and spe-
cificity toward their complementary DNA and RNA target
molecules. Consequently, an increase in melting temper-
ature (Tm) of + 1–8°C per introduced LNA monomer
against complementary DNA, and of + 2–10°C per mon-
omer against complementary RNA, as compared to
unmodified duplexes, have been reported. Aside from
being highly efficient as Northern blot probes, LNA-mod-
ified oligonucleotides can also be useful for addressing
the spatial expression of miRNAs by in situ hybridization
as well as for expression profiling by spotted microarrays
containing different LNA-modified capture probes
designed to detect both mature and precursor miRNAs.
Besides being experimentally discovered, the existence of
miRNAs can be predicted through sophisticated pattern
recognition techniques that use the knowledge derived
from a set of known miRNAs in order to train a computer
program to identifying potential novel miRNA sequences.
The combination of multiple properties with appropri-
ately different weights is required for an authentic detec-
tion. Most algorithms depend on evolutionary
conservation of miRNA sequences between different spe-
cies: they receive as input sequences that are homologous
in two species, and use various procedures to detect miR-
NAs that are conserved. Open entry servers provide access
to a number of RNA folding and prediction algorithms
such as Mfold, which models the folding patterns of con-
served RNA sequences [51] or MiRscan [52], which
employs the RNAFold algorithm [53] in the Vienna RNA
package. These procedures allow excluding many false-
positive candidates, but are limited to detecting conserved
miRNAs. Unlike other techniques, the PalGrade algo-
rithm [48] allows a selection of miRNA candidates that
does not depend on sequence conservation. By integrating
this algorithm with microarray experiments, it was possi-
ble to detect a large number of miRNAs that seem to be
unique to primates: out of 89 novel, validated, human
miRNAs, 54 were primate-specific [48]. Altogether, it is
estimated that 1–2% of mammalian genomes encodes
miRNAs [54,55]. Vertebrate miRNAs can be grouped into
families in line with their expression at specific time
points. The switch from one family to another is accom-
panied by a change in the expression profile of a cell and
its restriction towards a particular lineage: probably miR-
NAs help tuning the lineage-specificity of cellular protein
levels. It is likely that progenitor-specific miRNAs will also
exist. Studies that combined bioinformatic predictions
with high throughput experimental methods have sug-
gested that the total number of human miRNAs is at least
800, only 400–500 of which are expected to be conserved
[33,48].
MicroRNA targets
The comprehensive identification of miRNA targets is
much more complex, as no high throughput experimental
methods are at hand. Predicting mRNAs as miRNA targets
is computationally hard, since animal miRNAs are only
partly complementary to their target mRNAs, and the sig-
nificance of the mismatches is ambiguous. Furthermore,
the interaction between a miRNA and its target is proba-
bly not simply a RNA hybridization reaction since it may
be affected by proteins in the RISC complex. Unlike
miRNA prediction, there does not exist a large enough
group of known targets which can be used as a training set
for machine learning. Accordingly, the approach for
miRNA target prediction is based on empiric evidence.
Different aspects of miRNA binding to its targets serve as
the basis for prediction. A feature of central importance is
the so called "nucleus" or "seed" region at the 5' end:
nucleotides 2–8 in the miRNA, often flanked by adenos-
ines, which do often complement the target very closely
and are conserved among families of miRNAs [33,56].
This seed has been shown to be critical, and in some cases
sufficient, for miRNAs to suppress their targets. There is
also evidence that the 3'end of a miRNA may compensate
for insufficient base-pairing of its 5' seed. Popular target
prediction algorithms, usually freely accessible via web,
are Diana-MicroT [57,58], miRanda [59,60], PicTar
[56,61], RNAhybrid [62,63], TargetBoost [64], TargetScan
[33,65] and miRNA – Target Gene Prediction at EMBLBMC Neuroscience 2006, 7(Suppl 1):S5
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[66]. Predictions have led to the proposal that a single
miRNA can bind to a large number of mRNAs; in flies a
single miRNA is predicted to have, on the average, 54 tar-
gets, a figure that raises to about 200 in humans
[33,56,67]. Studies showed that miRNA function may
depend on binding to multiple binding-sites in the same
mRNA target [68,69]. It is calculated that 30–40% of all
targeted transcripts have more than one anchor sites for
single miRNAs. In addition to having multiple targets of a
single miRNA, a mRNA can bind to multiple different
miRNAs. In some instances, miRNAs have been shown to
function in a collaborative manner: when any one of the
two let-7 miRNA binding sites on its target lin-41 mRNA
in zebrafish is replaced by a miR-221 binding site, then
both miRNAs are needed to inhibit this target [68]. The
most complete miRNA target predictions were made in
flies by taking into account the genomes of several differ-
ent insect species [67,70]. Out of around 10,000 unique
genes in Drosophila melanogaster, at least 15% are predicted
to be regulated by at least one miRNA; one fifth of these
targets could be subject to coordinate control by two or
more miRNAs from different families. In mammals, from
30 to 50% of total mRNAs appear to be targeted by miR-
NAs, although this last point is still controversial
[33,48,71,72]. It should be kept in mind that only a small
number of predictions have actually been biologically val-
idated.
A full list of miRNA targets should not only describe spe-
cific mRNAs, but how the entire group of targets regulates
some biological function. For example, several miRNAs
(let-7b, miR-30, miR-98, miR-103, and miR-135) whose
expression is induced during neuronal differentiation of
embryonic carcinoma cells are predicted to target prefer-
entially neurogenesis-associated mRNAs [73], and a list of
miR-124 targets is rich in mRNAs for RNA binding pro-
teins [59]. Frequently, potential miRNA targets are found
to be regulatory genes themselves, like transcription fac-
tors, RNA binding proteins and post-translational modifi-
ers. For instance, Drosophila  target genes annotated as
transcription or translation factors are detected twice and
four times more frequently, respectively, than expected by
chance. Clearly, the combined action of miRNAs and tran-
scription factors is able to tune protein expression in a
manner that cannot be achieved by transcription factors
alone. For instance, human cell granulopoiesis is control-
led by a mini circuit including miR-223 and the two tran-
scription factors NF1-A and C/EBPalpha [74]. Analysis of
the functional annotations of target genes in Drosophila
indicates that miRNAs regulate a large variety of genes in
many different biological processes. These potential tar-
gets are rich in genes that are expressed at specific devel-
opmental stages and that are involved in cell fate
specification, morphogenesis and the coordination of
developmental processes, as well as genes that are active
in mature nervous system.
MicroRNA in brain
Many miRNAs are highly conserved in different organ-
isms, while others appear to readily enter and exit the
genome, or to be created in viruses. The miRNA database
at Sanger Center [75] lists over three thousand eight hun-
dred unique mature miRNA sequences from different spe-
cies: 462 are of human origin and a large fraction is
present in brain at different levels [73,76-86]. About
20%–40% of miRNAs in brain appear to be developmen-
tally regulated; the expression of certain families increases
dramatically in parallel with cortical development
[73,82,86]. The events that characterize neuronal differen-
tiation and synapse formation are clearly associated with
a distinct miRNA profile [76]. Clear-cut partitions in
miRNA expression are also detected in the course of pri-
mary neuron differentiation in culture, with some miR-
NAs (miR-124, miR-128) preferentially expressed in
neurons, some (miR-23, miR-26, miR-29) restricted to or
more strongly expressed in astrocytes, and some (miR-9,
miR-125) evenly distributed between these cell types [87].
Other conditions in which specific miRNAs are expressed
include retinoic acid induced neuronal differentiation of
embryonic carcinoma cells, and stem cells undergoing
neural differentiation [34,73,88].
Target gene predictions in Drosophila suggest that miRNAs
in the nervous system may take part in cell fate decisions,
neural connectivity, cell shape and adhesion, and synapse
function. Many neural transcription factors appear to be
targets [70]. A large number of predicted target genes are
implicated in cell fate decisions in the course of develop-
ment; many of the developmental factors are re-employed
in the mature nervous system to control synaptic function
[70]. Several presumptive miRNA target genes are compo-
nents of the Notch pathway [89,90]. These include factors
that bind to Notch or modify its sensitivity to ligands, and
Notch signalling target genes like hairy and several tran-
scriptional regulators of the E(spl) and Bearded com-
plexes [91].
Genes in these two complexes have short (6–7 nucle-
otide) conserved motifs in their 3' UTRs, which are
involved in post-transcriptional control and are comple-
mentary to D. melanogaster miRNAs (miR-2, -4, -5, -6, -7,
-11 and -79) [90]. In addition, predicted miRNA targets
include factors involved in the asymmetric cell division of
neuroblasts and transcription factors regulating different
aspects of neuronal differentiation. Many predicted
miRNA targets are secreted and trans-membrane factors
that mediate the growth and guidance of axons and den-
drites, and the formation of synapses. All these factors are
conserved and have similar axon guidance functions inBMC Neuroscience 2006, 7(Suppl 1):S5
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vertebrates. In addition, Drosophila miRNAs appeared to
hit the cellular machinery that effects cell shape change
and adhesion, including regulators and components of
the cytoskeleton and of the cell junctions. Additional
miRNA target genes that are active in the mature nervous
system include neurotransmitter receptors, ion channels
and pumps, as well as factors involved in neurotransmit-
ter transport and synaptic release. According to a compu-
tational analysis, however, only a small number of
regulatory miRNA-mRNA relationships appeared to be
conserved between flies and mammals [67].
Neuronal differentiation
Current research confirms a conserved role for miRNAs in
proper development and maintenance of the central nerv-
ous system in mammals. miRNAs might act not only to
change cell fate initially, but also to stabilize it at a later
stage, by maintaining lineage-specific expression patterns.
During differentiation, progenitor cells express families of
miRNAs in a sequential manner [82], resulting in lineage-
specific changes in the translation of subsets of transcripts.
The great variety of neuronal cell types may utilize miR-
NAs to lock in a precise identity notwithstanding the gene
fluctuations that normally occur in cells. This role may be
most vital in cells derived from the same lineage that dif-
fer in only minute traits from each other. The global effect
of given miRNAs on a set of targets may be to help estab-
lish a transcriptional profile characteristic of the cell in
which the miRNAs are normally expressed. Tissue specific
expression of miRNAs may therefore constitute a sort of
"miRNA code", dictating in part the tissue-specific protein
expression profile [92-95] (Figure 2). In parallel, the
arrangement of miRNA binding sites in the 3' UTRs of
mRNAs would constitute another code that could be read
by the set of expressed miRNAs to tune product levels [96]
(Figure 3). The translation of all transcripts that share a 3'
UTR code would be regulated similarly. A possible exam-
ple are the mRNAs targeted by miR-124a, one of the most
abundant miRNAs in the brain. The binding motif for
miR-124a is also one of the most prevalent miRNA bind-
ing sites in the 3'UTRs of mammalian transcripts [97].
Injection of miR-124a into HeLa, a human carcinoma cell
line, cells caused the down-regulation of more than 100
messages and induced a new gene expression profile
resembling that of a mature neuron [98]. Other studies
have suggested that over-expression of the pro-neural
transcription factors MASH1 and neurogenin promotes
differentiation of neural progenitor cells into neurons, in
part by inducing miR-124a expression [99]. The miRNA
functions in cell differentiation and growth control,
together with the location of some miRNA genes at sites
of translocation or deletion breakpoints, has led to the
idea that these molecules could play a relevant role in can-
cer development [55,100,101]. In the highly malignant
brain tumor glioblastoma, the presence of markedly ele-
vated levels of miR-21 may contribute to the malignant
phenotype by acting as an anti-apoptotic factor [102].
Synaptic plasticity
There are several reasons to believe that miRNAs may fea-
ture prominently in the function of the nervous system.
Neuronal function is crucially determined by differential
gene activity between and even within cell compartments,
for example the different branches of a dendritic tree. The
distances between nucleus and neurite projections are rel-
atively long, making nuclear regulation of neurite proper-
ties problematic. As neuronal synapses are a site of active
protein synthesis, translational control appears to be
more efficient than transcriptional control for modulating
gene activity near the site of action. Several miRNAs are
found within the actively translating poly-ribosome frac-
tion, where they might work as mediators of translational
regulation [76,86]. Regulation by miRNAs would thus
provide an excellent additional mechanism of post-tran-
scriptional control of gene expression. In the case of axon
guidance, it has been shown that the relative abundance
of adhesion molecules and chemotropic receptors on the
surface of the growth cone is post-transcriptionally regu-
lated in response to external cues. Local control of protein
synthesis in mammalian dendrites is essential for synaptic
plasticity phenomena (e. g. LTP) that contribute to the
molecular basis for learning and memory formation
[103,104]. The brain derived neurotrophic factor BDNF,
which is essential for establishing LTP at hippocampal
synapses [104], regulates the local translation of a group
of mRNAs [105]. miRNAs may have a role in modulating
local translation in response to changes in synaptic activ-
ity, thus regulating synaptic strength and growth of spines
[96,106]. According to this view, a set of miRNAs would
inhibit the translation of associated mRNAs under basal
conditions, with the plausible support of RNA binding
protein(s). The inhibition would be released as a conse-
quence of synaptic activity, leading to de-repression of a
set of mRNAs for post-synaptic proteins capable of
strengthening the synaptic response (Figure 4). One con-
nection between miRNAs and the mechanism of transla-
tional inhibition might be supplied by RNA binding
proteins, like FMRP, complexed with messenger ribonu-
cleoproteins (mRNPs) and poly-ribosomes. A current
model considers FMRP, or functionally similar RNA bind-
ing proteins, as a platform that localizes to appropriate
dendritic sites a set of mRNAs, which encode the compo-
nents required for enhancing synaptic response or growth.
Such translation platforms may be turned on by carefully
promoting the translation of critical mRNAs and turned
off by directing miRNAs to mRNAs on the platform or to
the mRNA encoding the platform protein(s) itself [34].BMC Neuroscience 2006, 7(Suppl 1):S5
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miRNA syndromes?
It must not be surprising that miRNA biogenesis and func-
tion are implicated in neurological disease.
One example is Tourette's syndrome, a developmental
neuropsychiatric disorder characterized by vocal and
motor tics. Recent findings point to its association with
rare sequence variants of the gene encoding the trans-
membrane protein SLITRK1 (Slit and Trk-like 1), on chro-
mosome 13q31.1 [107]. Wild-type SLITRK1 enhances
dendritic growth in primary neuronal cultures. Variants
influencing the binding site for human miR-189 in the
3'UTR region of the gene were found in some affected
people but not in control chromosomes. Interestingly,
SLITRK1 mRNA and human miR-189 showed an overlap-
ping expression pattern in brain regions implicated in
Tourettes syndrome.
A second case is DiGeorge syndrome, a frequent disease
characterized by a variety of defects, including schizophre-
nia and obsessive-compulsive disorder. The gene for the
double-stranded RNA-binding protein DGCR8, involved
Regulation of neuronal differentiation through miRNAs Figure 3
Regulation of neuronal differentiation through miRNAs. The neural factor NF, such as a neurotrophin (BDNF, NGF) 
or a neurotransmitter (glutamate, serotonin), interacts with its receptor, activating a signalling cascade that switches on tran-
scription of selected neural genes, including specific miRNA genes as well. miRNAs, in turn, can inhibit translation of proteins 
regulating neuronal development, for instance a neural repressor protein. Such a regulated circuit of gene expression has been 
recently demonstrated for neuronal morphogenesis triggered by the cAMP-response element binding protein CREB [95]. This 
transcriptional activator has a central role in neural specific gene expression, being implicated in many neuronal processes like 
differentiation, plasticity, LPT, and memory formation. miR 132, whose transcription is activated by neurotrophins and is under 
direct CREB control, interacts with 3'UTR of the mRNA coding for the GTPase-activating protein p250GAP. This protein is a 
repressor of neuronal differentiation: its inhibition promotes neurite outgrowth.
NF
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Neural Protein
mRNA
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in miRNA processing as an essential Drosha co-factor,
maps in a region in chromosome 22 (22q11.2) which is
commonly deleted in people affected by the disease
[101,108]. This finding suggests that defects in miRNA
biogenesis may contribute to the widespread develop-
mental abnormalities affecting DiGeorge syndrome
patients.
The third example is Fragile × syndrome, the most com-
mon inherited cause of human mental retardation. The
disease is most often caused by a trinucleotide (CGG)
repeat expansion in the fragile × mental retardation 1
gene, encoding the RNA-binding protein FMRP, which is
found in neurons and transported into dendrites. FMRP is
involved in transport and localization of a subset of neu-
Potential function of miRNAs in synaptic plasticity Figure 4
Potential function of miRNAs in synaptic plasticity. Three different synapses for a single neuron are shown. Only the 
central one is active, as it receives an electrical pulse, and is potentiated. In the inactive synapses, translation of synaptic 
mRNAs (red and yellow) is prevented by miRNAs (miR) interacting with their 3'UTRs, an interaction supposedly stabilized by 
RNA binding proteins (RBP). A synaptic stimulus SS, represented by a neurotrophin or a neurotransmitter (e. g. BDNF and 
glutamate, respectively), is sensed by a receptor, in pink (e.g. TrkB or the NMDA receptor), and transmitted inside the neuron, 
in the vicinity of the active synapse. This signals triggers dissociation of the mRNA:miRNA:RBP complex, allowing the local 
translation of synaptic mRNAs. The neo-synthesized proteins (e. g. an AMPA receptor, in red, or some other synaptic compo-
nent, in yellow) are utilized at the active synapse, contributing to strengthen its response.
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ronal mRNAs as well as in regulating their translation, and
appears to play an important role in dendritic spine mat-
uration or plasticity [109]. FMRP associates with miRNAs
in both Drosophila and mammals, indicating that it may
regulate translation via the miRNA pathway [110]. miR-
NAs could function similarly to BC1 noncoding dendritic
RNA to determine the specificity of FMRP function by
linking the regulated mRNAs to FMRP [23].
Conclusion
Despite the fact that non coding RNAs in brain have been
characterized only recently, a large amount of experimen-
tal data indicate their importance in brain development
and function. They clearly seem to be involved in all
mechanisms of synaptic plasticity like memory and stress
response. Furthermore, anomalous non coding RNA
expression has been linked to several brain dysfunctions
in humans, suggesting their possible targeting for thera-
peutic treatment or their use as therapeutic tools.
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